Alan Edrick
Analyst · Drexel Hamilton. Your line is now open
Thank you, Deepak. Now let's review the financial results for the first fiscal quarter in greater detail. As mentioned previously, our revenues in Q1 of fiscal '19 increased by 4% year-over-year. Q1 revenues in the Security division increased by 5% from Q1 of fiscal '18, driven by strong growth in cargo and vehicle inspection equipment sales. In addition, as our installed base has grown, Security division field service revenues have also increased. The 20% year-over-year revenue growth reported for our Opto division was driven by revenues from the flex circuit businesses acquired in January '18, and from our optical sensor and higher level assemblies business acquired in July '18, as well as ongoing strength in both organic external sales and intercompany sales, primarily to our Security division. As Deepak mentioned, we experienced continued challenges in the Healthcare divisions as revenues fell 16% compared to Q1 of the same prior year period. Our Q1 gross margin was 36.0% compared to 35.5% in Q1 of last year. This improvement was driven by improvements in our Opto division as a result of favorable product mix and improved operating efficiencies as well as improvement in the gross margin in our Healthcare division, as decreased sales were countered by our focus on more profitable product lines. Again, the 36% gross margin was the highest in the first fiscal quarter in eight years. As mentioned on previous calls, our gross margin will fluctuate from period-to-period based on revenue mix among other factors. Moving to operating expenses. In Q1 of fiscal '19, SG&A expenses were up $6 million, primarily due support the Security and Opto division growth as well as due to the added expenses from the two Opto division acquisitions mentioned previously. We continue to focus in all of our divisions on improving efficiencies and prudently managing our cost structure. R&D expenses in Q1 were $13.8 million, down by $1.3 million from Q1 of the prior year, due to efficiencies in our Security division from consolidation of operations of acquired businesses, post acquisitions, and Healthcare division reductions from our de-emphasis on anesthesia products, as mentioned on last quarter's call. We remain focused on innovative product development, which we view as vital to the long term success of our business. Restructuring and other charges were $4.2 million in Q1 of fiscal '19. This current year amount primarily consisted of legal costs associated with litigation and investigations as well as acquisition related and employee severance costs. Moving to taxes. Excluding the impact of discrete tax items, the company's effective tax rate was 28.1% in Q1 of fiscal '19 compared to 28.3% in Q1 of fiscal '18. During the 3 months ended September 30, '18, we've recognized a discrete tax benefit for equity based compensation of $1.5 million under ASU-2016-09 resulting in an effective tax rate of 13.9%. During the three months ended September 30, 2017, we've recognized an approximate $700,000 net discrete tax charge resulting in an effective tax rate of 32.9%. Let's now turn to a discussion of our non-GAAP adjusted operating margin, which excludes the items mentioned earlier in the call. The company's non-GAAP adjusted operating margin was 9.2% in Q1 of fiscal '19, down slightly from 9.4% in Q1 of fiscal '18. This decrease resulted from decreased operating margin in the Security division, due to reduced Mexico contract revenues, among other factors, and Healthcare division losses, offset partially by margin expansion in the Opto division. Moving to cash flow. In Q1 of fiscal '19, we used $2.8 million in operating cash flow. Cash flow was impacted by a buildup of inventories to support expected shipments over the remainder of fiscal '19, taxes paid as we took advantage of certain repatriation opportunities, and higher day's sales outstanding or DSO, due to the timing of customer collections. DSO was 76 days in Q1 of fiscal year '19 as compared to 72 days in Q1 of fiscal '18. Capital expenditures in the quarter were $7.9 million, which included amounts pertaining to the new turnkey program we announced last year, and Deepak referenced earlier, while depreciation and amortization was $14.1 million. Our balance sheet remains strong. We ended the quarter with net leverage of approximately 1.9. And finally turning to our guidance. We are raising our fiscal year 2019 sales guidance to a range of $1.14 billion to $1.175 billion. And we are increasing our fiscal year 2019 non-GAAP earnings per share -- per diluted share guidance through $3.85 to $4.05. This non-GAAP diluted EPS range excludes restructuring and other charges and amortization, acquired intangible assets and non-cash interest expense and their associated tax effects and discrete tax items. Additionally, we continue to evaluate the impact of tax reform on our effective tax rate, including the effect of new taxes associated with computations for the global intangible low income tax known as GILTI, and foreign derived intangible income known as FDII. Each of these provisions is complex. The effective tax rate is subject to significant volatility and will be updated as more analysis and information is available. We currently believe the sales and earnings guidance reflect reasonable estimates. Actual sales and earnings, however, could vary from the anticipated ranges due to the risks and uncertainties, specifically affecting our business and generally affecting industries in which we operate. These risks and uncertainties include items beyond our control, such as site readiness or product installations, evolving government trade policies, customer acceptance and the timing of orders in each division and other risks and uncertainties discussed in our SEC filings. We've continued to grow our business, while investing in product development and making selective strategic acquisitions. Our products and acquisition investments enable OSI to continue our leadership role with innovative products and solutions across our various industries. Thank you for participating in this conference call. And at this time, we would like to open the call to questions.